References to the "Company," "Parsec Capital Acquisitions Corp.," "our," "us" or
"we" refer to Parsec Capital Acquisitions Corp. The following discussion and
analysis of the Company's financial condition and results of operations should
be read in conjunction with the unaudited interim condensed financial statements
and the notes thereto contained elsewhere in this report. Certain information
contained in the discussion and analysis set forth below includes
forward-looking statements that involve risks and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q includes forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Exchange Act. We have based these forward-looking statements
on our current expectations and projections about future events. These
forward-looking statements are subject to known and unknown risks, uncertainties
and assumptions about us that may cause our actual results, levels of activity,
performance or achievements to be materially different from any future results,
levels of activity, performance or achievements expressed or implied by such
forward-looking statements. In some cases, you can identify forward-looking
statements by terminology such as "may," "should," "could," "would," "expect,"
"plan," "anticipate," "believe," "estimate," "continue," or the negative of such
terms or other similar expressions. Factors that might cause or contribute to
such a discrepancy include, but are not limited to, those described in our other
SEC filings.
Overview
We are a blank check company incorporated as a Delaware corporation and formed
for the purpose of effecting a merger, capital stock exchange, asset
acquisition, stock purchase, reorganization or similar business combination with
one or more businesses. We intended to effectuate our Business Combination using
cash from the proceeds of the Initial Public Offering and the sale of the
Private Placement Warrants, our capital stock, debt or a combination of cash,
stock and debt.
The Company has determined that it is in the best interests of the Company and
its stockholders to dissolve and liquidate in accordance with the provisions of
Amended and Restated Certificate of Incorporation, due to the Company's
inability to consummate an initial Business Combination by October 8, 2022, the
Liquidation Date. The Company will redeem all of the Public Shares, at a
per-share price, payable in cash, equal to the aggregate amount then on deposit
in the Trust Account including interest earned on the funds held in the Trust
Account and not previously released to the Company to pay its tax obligations
(less up to $100,000 of interest to pay dissolution expenses), divided by the
number of then outstanding Public Shares, which redemption will completely
extinguish public stockholders' rights as stockholders (including the right to
receive further liquidating distributions, if any). There will be no redemption
rights or liquidating distributions with respect to the Company's warrants,
which will expire worthless.
Additionally, the amended articles of incorporation state that the Company must
wind up and dissolve if the Company is unable to complete its Business
Combination within the Combination Period and no extension is exercised, subject
to approval by the Company's board of directors and any remaining shareholders.
The Company is seeking board approval to amend the articles of incorporation to
continue the Company as it looks to complete its Business Combination, see
below. There is no assurance the amendment to the articles of incorporation will
be approved by the Company's board of directors and any remaining shareholders.
Results of Operations
We have neither engaged in any operations nor generated any operating revenues
to date. Our only activities from inception through September 30, 2022 were
organizational activities and those necessary to consummate our initial public
offering and identifying a target company for an initial Business Combination.
We do not expect to generate any operating revenues until after the completion
of our business combination. We expect to incur increased expenses as a result
of being a public company (for legal, financial reporting, accounting and
auditing compliance), as well as for due diligence expenses.
For the three months ended September 30, 2022, we had a net income of $88,005,
which consists of formation and operating costs of $265,405 and provision for
income taxes of $42,704, offset by bank interest income of $943 and trust
interest income of $395,171.
For the nine months ended September 30, 2022, we had a net loss of $296,641,
which consists of formation and operating costs of $778,280 and provision for
income taxes of $42,704, offset by bank interest income of $1,066 and trust
interest income of $523,277.
For the three months ended September 30, 2021 and for the period from February
11, 2021 (inception) to September 30, 2021, we had a net loss of $24 and $582,
which consists of formation costs.
Liquidity and Capital Resources
As of September 30, 2022, we had $297,974 in cash and a working capital deficit
$292,708. Until the consummation of our initial public offering, our liquidity
needs were satisfied through the receipt of $25,000 from our sale of the Founder
Shares, and unsecured loans and advances in an aggregate of $118,710 from
related parties.
For the nine months ended September 30, 2022, cash used in operating activities
was $270,595. Net loss of $296,641 was affected by interest earned on marketable
securities held in the Trust Account of $523,277. Changes in operating assets
and liabilities provided $549,323 of cash used in operating activities.
For the period from February 11, 2021 (inception) to September 30, 2021, cash
used in operating activities was $194 and net loss of $582 was affected by
formation cost paid by Sponsor of $388. There were no changes in operating
assets and liabilities.
18
On October 8, 2021, we consummated our initial public offering of 8,625,000
units, including the full exercise of the underwriters' over-allotment option to
purchase 1,125,000 units, at $10.00 per Unit, generating gross proceeds of
$86,250,000.
Simultaneously with the closing of our initial public offering, our Sponsor
purchased an aggregate of 4,518,750 warrants at a price of $1.00 per warrant,
for an aggregate purchase price of $4,518,750, in a private placement.
Upon completion of the IPO on February 1, 2021, transaction costs amounted to
$5,174,429 consisting of $1,725,000 of underwriting commissions, $3,018,750 of
deferred underwriting commissions, and $430,679 of other offering costs.
Following the closing of our initial public offering and the sale of
over-allotment units, an aggregate of $87,543,750 from the net proceeds and the
sale of the Private Placement Warrants was held in a Trust Account.
We intend to use the funds held outside the Trust Account primarily to identify
and evaluate target businesses, perform business due diligence on prospective
target businesses, travel to and from the offices, plants or similar locations
of prospective target businesses or their representatives or owners, review
corporate documents and material agreements of prospective target businesses,
and structure, negotiate and complete a business combination.
Going Concern
In connection with the Company's assessment of going concern considerations in
accordance with the authoritative guidance in Financial Accounting Standard
Board ("FASB") Accounting Standards Update ("ASU") 2014-15,"Disclosures of
Uncertainties about an Entity's Ability to Continue as a Going Concern,"
management has determined that the mandatory liquidation date and subsequent
dissolution, should the Company be unable to complete a Business Combination,
raises substantial doubt about the Company's ability to continue as a going
concern. The Company had until October 8, 2022 to consummate a Business
Combination. The Company will be unable to consummate a Business Combination by
the Liquidation Date and intends to dissolve and liquidate in accordance with
the provisions of the Amended and Restated Certificate of Incorporation. No
adjustments have been made to the carrying amounts of assets or liabilities
should the Company be required to liquidate after October 8, 2022. (see Note 9)
Risks and Uncertainties
Management is continuing to evaluate the impact of the COVID-19 pandemic and the
Russia-Ukraine war and has concluded that while it is reasonably possible that
it could have a negative effect on our financial position, results of its
operations and/or search for a target company, the specific impact is not
readily determinable as of the date of these unaudited condensed financial
statements. The unaudited condensed financial statements do not include any
adjustments that might result from the outcome of this uncertainty.
Off-Balance Sheet Arrangements; Commitments and Contractual Obligations
We have no obligations, assets or liabilities which would be considered
off-balance sheet arrangements as of September 30, 2022 and December 31, 2021.
We do not participate in transactions that create relationships with
unconsolidated entities or financial partnerships, often referred to as variable
interest entities, which would have been established for the purpose of
facilitating off-balance sheet arrangements. We have not entered into any
off-balance sheet financing arrangements, established any special purpose
entities, guaranteed any debt or commitments of other entities, or purchased any
non-financial assets.
19
Contractual obligations
We do not have any long-term debt, capital lease obligations, operating lease
obligations or long-term liabilities, other than an agreement to pay Astro
Aerospace Ltd., an affiliate of our sponsor, a monthly fee of $10,000 for office
space, utilities and secretarial and administrative services and deferred
underwriters' commission of $3,018,750. We began incurring these fees on October
6, 2021 and will continue to incur these fees monthly until the earlier of the
completion of a business combination and our liquidation.
Critical Accounting Policies
The preparation of unaudited condensed financial statements and related
disclosures in conformity with US GAAP requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities,
disclosure of contingent assets and liabilities at the date of the unaudited
condensed financial statements, and income and expenses during the periods
reported. Actual results could materially differ from those estimates. We have
not identified any critical accounting policies.
Recent Accounting Standards
Our management does not believe that any recently issued, but not effective,
accounting standards, if currently adopted, would have a material effect on the
accompanying financial statements.
Inflation
On August 16, 2022, the Inflation Reduction Act of 2022 (the "IR Act") was
signed into federal law. The IR Act provides for, among other things, a new U.S.
federal 1% excise tax on certain repurchases (including redemptions) of stock by
publicly traded domestic (i.e., U.S.) corporations and certain domestic
subsidiaries of publicly traded foreign corporations. The excise tax is imposed
on the repurchasing corporation itself, not its shareholders from which shares
are repurchased. The amount of the excise tax is generally 1% of the fair market
value of the shares repurchased at the time of the repurchase. However, for
purposes of calculating the excise tax, repurchasing corporations are permitted
to net the fair market value of certain new stock issuances against the fair
market value of stock repurchases during the same taxable year. In addition,
certain exceptions apply to the excise tax. The U.S. Department of the Treasury
(the "Treasury") has been given authority to provide regulations and other
guidance to carry out and prevent the abuse or avoidance of the excise tax. The
IR Act applies only to repurchases that occur after December 31, 2022.
Any redemption or other repurchase that occurs after December 31, 2022, in
connection with a Business Combination, extension vote or otherwise, may be
subject to the excise tax. Whether and to what extent the Company would be
subject to the excise tax in connection with a Business Combination, extension
vote or otherwise would depend on a number of factors, including (i) the fair
market value of the redemptions and repurchases in connection with the Business
Combination, extension or otherwise, (ii) the structure of a Business
Combination, (iii) the nature and amount of any "PIPE" or other equity issuances
in connection with a Business Combination (or otherwise issued not in connection
with a Business Combination but issued within the same taxable year of a
Business Combination) and (iv) the content of regulations and other guidance
from the Treasury. In addition, because the excise tax would be payable by the
Company and not by the redeeming holder, the mechanics of any required payment
of the excise tax have not been determined. The foregoing could cause a
reduction in the cash available on hand to complete a Business Combination and
in the Company's ability to complete a Business Combination.
At this time, it has been determined that none of the IR Act tax provisions have
an impact to the Company's fiscal 2022 tax provision. The Company will continue
to monitor for updates to the Company's business along with guidance issued with
respect to the IR Act to determine whether any adjustments are needed to the
Company's tax provision in future periods.
Emerging Growth Company Status
We are an "emerging growth company," as defined in Section 2(a) of the
Securities Act of 1933, as amended, (the "Securities Act"), as modified by the
Jumpstart our Business Startups Act of 2012, (the "JOBS Act"), and it may take
advantage of certain exemptions from various reporting requirements that are
applicable to other public companies that are not emerging growth companies
including, but not limited to, not being required to comply with the auditor
attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced
disclosure obligations regarding executive compensation in our periodic reports
and proxy statements, and exemptions from the requirements of holding a
nonbinding advisory vote on executive compensation and stockholder approval of
any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies
from being required to comply with new or revised financial accounting standards
until private companies (that is, those that have not had a Securities Act
registration statement declared effective or do not have a class of securities
registered under the Exchange Act) are required to comply with the new or
revised financial accounting standards. The JOBS Act provides that a company can
elect to opt out of the extended transition period and comply with the
requirements that apply to non-emerging growth companies but any such election
to opt out is irrevocable. We have elected not to opt out of such extended
transition period which means that when a standard is issued or revised and it
has different application dates for public or private companies, us, as an
emerging growth company, can adopt the new or revised standard at the time
private companies adopt the new or revised standard. This may make comparison of
our unaudited condensed financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has
opted out of using the extended transition period difficult or impossible
because of the potential differences in accounting standards used.
20
© Edgar Online, source Glimpses